{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:11:06Z","timestamp":1788379866471,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"IlDong Pharmaceutical Co, Ltd"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.clinthera.2019.08.020","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T14:23:14Z","timestamp":1569507794000},"page":"2273-2282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacokinetic Interaction Among Telmisartan, Amlodipine, and Hydrochlorothiazide After a Single Oral Administration in Healthy Male Subjects"],"prefix":"10.1016","volume":"41","author":[{"given":"Seol Ju","family":"Moon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Young","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Sang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Gul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2019.08.020_bib1","series-title":"Cardiovascular Disease Fact Sheet","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.clinthera.2019.08.020_bib2","series-title":"A\u00a0Global Brief on Hypertension: Silent Killer, Global Public Health Crisis, (WHO\/DCO\/WHD\/2013.2)","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.clinthera.2019.08.020_bib3","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2019.08.020_bib4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) [published correction appears in JAMA. 2014;311:1809","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2019.08.020_bib5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","article-title":"Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials","volume":"122","author":"Wald","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2019.08.020_bib6","series-title":"MICARDIS\u00ae (Telmisartan) Tablets: US Prescribing Information. Ridgefield (CT)","year":"2018"},{"key":"10.1016\/j.clinthera.2019.08.020_bib7","series-title":"NORVASC\u00ae (Amlodipine Besylate) Tablets: US Prescribing Information","year":"2010"},{"key":"10.1016\/j.clinthera.2019.08.020_bib8","series-title":"TWYNSTA\u00ae (Telmisartan\/amlodipine) Tablets: US Prescribing Information. Ridgefield (CT)","year":"2009"},{"key":"10.1016\/j.clinthera.2019.08.020_bib9","series-title":"MICARDIS\u00ae HCT (Telmisartan and Hydrochlorothiazide) Tablets: US Prescribing Information. Ridgefield (CT)","year":"2018"},{"key":"10.1016\/j.clinthera.2019.08.020_bib10","series-title":"Guideline on Bioanalytical Method Validation","year":"2013"},{"key":"10.1016\/j.clinthera.2019.08.020_bib11","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jpba.2008.08.021","article-title":"Liquid chromatographic-tandem mass spectrometric method for the simultaneous quantitation of telmisartan and hydrochlorothiazide in human plasma","volume":"48","author":"Yan","year":"2008","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.clinthera.2019.08.020_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4236\/pp.2013.42027","article-title":"Determination of amlodipine in human plasma by LC-MS\/MS and its bioequivalence study in healthy Chinese subjects","volume":"4","author":"Lv","year":"2013","journal-title":"Pharmacol Pharm"},{"key":"10.1016\/j.clinthera.2019.08.020_bib13","first-page":"793","article-title":"Rapid determination of hydrochlorothiazide in human plasma by high performance liquid chromatography-tandem mass spectrometry","volume":"28","author":"Sousa","year":"2009","journal-title":"Lat Am J Pharm"},{"key":"10.1016\/j.clinthera.2019.08.020_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/jhh.2015.24","article-title":"Combination antihypertensive therapy in clinical practice. The analysis of 1254 consecutive patients with uncontrolled hypertension","volume":"30","author":"Petrak","year":"2016","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.clinthera.2019.08.020_bib15","first-page":"703","article-title":"Drug-drug interactions study of triple combination of telmisartan 80 mg, amlodipine 5 mg and hydrochlorothiazide 12.5 mg at the steady-state in Japanese healthy volunteers","volume":"44","author":"Nakamichi","year":"2016","journal-title":"Jpn Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2019.08.020_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinthera.2017.11.006","volume":"40","author":"Sung","year":"2018","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2019.08.020_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-0033-1334882","article-title":"A\u00a0comparative pharmacokinetic study of a fixed dose combination for essential hypertensive patients: a randomized crossover study in healthy human volunteers","volume":"63","author":"Gorain","year":"2013","journal-title":"Drug Res (stuttg)"},{"key":"10.1016\/j.clinthera.2019.08.020_bib18","series-title":"MICROZIDE\u00ae (Hydrochlorothiazide) Capsules: US Prescribing Information","year":"2011"},{"key":"10.1016\/j.clinthera.2019.08.020_bib19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1124\/dmd.113.055400","article-title":"Amlodipine metabolism in human liver microsomes and roles of CYP3A4\/5 in the dihydropyridine dehydrogenation","volume":"42","author":"Zhu","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.clinthera.2019.08.020_bib20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0022-3565(24)38896-2","article-title":"Interaction and transport of thiazide diuretics, loop diuretics, and acetazolamide via rat renal organic anion transporter rOAT1","volume":"295","author":"Uwai","year":"2000","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.clinthera.2019.08.020_bib21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/bdd.699","article-title":"Interaction of angiotensin receptor type 1 blockers with ATP-binding cassette transporters","volume":"31","author":"Weiss","year":"2010","journal-title":"Biopharma Drug Dispos"},{"key":"10.1016\/j.clinthera.2019.08.020_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2125.2006.02733.x","article-title":"Effect of ABCB1 (MDR1) haplotypes derived from G2677T\/C3435T on the pharmacokinetics of amlodipine in healthy subjects","volume":"63","author":"Kim","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2019.08.020_bib23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cardiores.2006.07.014","article-title":"Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma","volume":"72","author":"Imayama","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.clinthera.2019.08.020_bib24","series-title":"Guidance for Industry: Hypertension: Developing Fixed-Combination Drug Products for Treatment","author":"Food and Drug Administration Center for Drugs Evaluation Research","year":"2018"},{"key":"10.1016\/j.clinthera.2019.08.020_bib25","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/jch.13240","article-title":"Fixed-dose vs free-dose combinations for the management of hypertension\u2014an analysis of 81 958 patients","volume":"20","author":"Bramlage","year":"2018","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.clinthera.2019.08.020_bib26","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/ajh\/hpt035","article-title":"Dynamic view on affordability of fixed-dose combination antihypertensive drug therapy","volume":"26","author":"Hong","year":"2013","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.clinthera.2019.08.020_bib27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2165\/00003088-199936060-00004","article-title":"Drug interactions with tobacco smoking. An update","volume":"36","author":"Zevin","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2019.08.020_bib28","first-page":"131","article-title":"Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test","volume":"9","author":"Tantcheva-Poor","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.clinthera.2019.08.020_bib29","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1177\/009127000004001206","article-title":"Pharmacokinetics of repeated oral doses of amlodipine and amlodipine plus telmisartan in healthy volunteers","volume":"40","author":"Stangier","year":"2000","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2019.08.020_bib30","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1177\/009127000004001203","article-title":"Multiple-dose pharmacokinetics of telmisartan and of hydrochlorothiazide following concurrent administration in healthy subjects","volume":"40","author":"Young","year":"2000","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2019.08.020_bib31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/FJC.0b013e318237389e","article-title":"Assessment of the drug-drug interactions between fimasartan and hydrochlorothiazide in healthy volunteers","volume":"59","author":"Jeon","year":"2012","journal-title":"J\u00a0Cardiovasc Pharmacol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291819304242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291819304242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:50:45Z","timestamp":1758963045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291819304242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0149291819304242"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2019.08.020","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetic Interaction Among Telmisartan, Amlodipine, and Hydrochlorothiazide After a Single Oral Administration in Healthy Male Subjects","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2019.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}